Pfizer and Germany-based partner BioNTech SE had hoped to roll out 100 million vaccines world-wide by the end of this year, a plan that has now been reduced to 50 million.
Source: Pfizer Slashed Its Original Covid-19 Vaccine Rollout Target After Supply-Chain Obstacles
